Partners Group Holding Valuation
Is PGHNZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PGHNZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PGHNZ (CHF1200.5) is trading above our estimate of fair value (CHF1198.12)
Significantly Below Fair Value: PGHNZ is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PGHNZ?
Other financial metrics that can be useful for relative valuation.
What is PGHNZ's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CHF 31.28b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 17.7x |
Enterprise Value/EBITDA | 28.3x |
PEG Ratio | 2.3x |
Price to Earnings Ratio vs Peers
How does PGHNZ's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 13.4x | ||
III 3i Group | 8x | 18.0% | UK£30.9b |
ICG Intermediate Capital Group | 13.1x | 4.2% | UK£6.1b |
SDR Schroders | 15x | 14.1% | UK£5.7b |
HL. Hargreaves Lansdown | 17.6x | 1.8% | UK£5.2b |
PGHNZ Partners Group Holding | 32.6x | 14.2% | CHF 31.3b |
Price-To-Earnings vs Peers: PGHNZ is expensive based on its Price-To-Earnings Ratio (32.6x) compared to the peer average (13.4x).
Price to Earnings Ratio vs Industry
How does PGHNZ's PE Ratio compare vs other companies in the GB Capital Markets Industry?
Price-To-Earnings vs Industry: PGHNZ is expensive based on its Price-To-Earnings Ratio (32.6x) compared to the UK Capital Markets industry average (12.7x).
Price to Earnings Ratio vs Fair Ratio
What is PGHNZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 32.6x |
Fair PE Ratio | 24.1x |
Price-To-Earnings vs Fair Ratio: PGHNZ is expensive based on its Price-To-Earnings Ratio (32.6x) compared to the estimated Fair Price-To-Earnings Ratio (24.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 1,200.50 | CHF 1,281.40 +6.7% | 9.9% | CHF 1,650.00 | CHF 1,120.00 | n/a | 15 |
Oct ’25 | CHF 1,290.50 | CHF 1,273.80 -1.3% | 9.2% | CHF 1,650.00 | CHF 1,120.00 | n/a | 15 |
Sep ’25 | CHF 1,226.00 | CHF 1,276.29 +4.1% | 5.7% | CHF 1,390.00 | CHF 1,150.00 | n/a | 14 |
Aug ’25 | CHF 1,189.00 | CHF 1,290.77 +8.6% | 5.4% | CHF 1,390.00 | CHF 1,150.00 | n/a | 13 |
Jul ’25 | CHF 1,147.00 | CHF 1,281.85 +11.8% | 7.3% | CHF 1,450.00 | CHF 1,150.00 | n/a | 13 |
Jun ’25 | CHF 1,208.00 | CHF 1,276.31 +5.7% | 8.7% | CHF 1,450.00 | CHF 1,040.00 | n/a | 13 |
May ’25 | CHF 1,191.00 | CHF 1,257.38 +5.6% | 9.5% | CHF 1,450.00 | CHF 1,040.00 | n/a | 13 |
Apr ’25 | CHF 1,289.50 | CHF 1,240.23 -3.8% | 9.2% | CHF 1,450.00 | CHF 1,040.00 | n/a | 13 |
Mar ’25 | CHF 1,266.00 | CHF 1,181.64 -6.7% | 10.0% | CHF 1,360.00 | CHF 920.00 | n/a | 14 |
Feb ’25 | CHF 1,172.00 | CHF 1,155.21 -1.4% | 9.4% | CHF 1,350.00 | CHF 920.00 | n/a | 14 |
Jan ’25 | CHF 1,212.50 | CHF 1,097.57 -9.5% | 11.5% | CHF 1,289.00 | CHF 860.00 | n/a | 14 |
Dec ’24 | CHF 1,157.00 | CHF 1,081.57 -6.5% | 11.3% | CHF 1,289.00 | CHF 860.00 | n/a | 14 |
Nov ’24 | CHF 965.80 | CHF 1,054.64 +9.2% | 11.6% | CHF 1,289.00 | CHF 860.00 | CHF 1,200.50 | 14 |
Oct ’24 | CHF 1,034.50 | CHF 1,054.64 +1.9% | 11.6% | CHF 1,289.00 | CHF 860.00 | CHF 1,290.50 | 14 |
Sep ’24 | CHF 954.90 | CHF 1,019.84 +6.8% | 15.0% | CHF 1,491.00 | CHF 860.00 | CHF 1,226.00 | 14 |
Aug ’24 | CHF 978.40 | CHF 1,018.51 +4.1% | 14.5% | CHF 1,491.00 | CHF 860.00 | CHF 1,189.00 | 15 |
Jul ’24 | CHF 839.80 | CHF 992.22 +18.1% | 8.5% | CHF 1,120.03 | CHF 848.00 | CHF 1,147.00 | 14 |
Jun ’24 | CHF 824.80 | CHF 960.08 +16.4% | 16.2% | CHF 1,120.03 | CHF 480.11 | CHF 1,208.00 | 15 |
May ’24 | CHF 865.40 | CHF 946.80 +9.4% | 16.4% | CHF 1,100.00 | CHF 480.11 | CHF 1,191.00 | 14 |
Apr ’24 | CHF 858.80 | CHF 985.41 +14.7% | 20.5% | CHF 1,491.00 | CHF 480.11 | CHF 1,289.50 | 15 |
Mar ’24 | CHF 879.40 | CHF 1,015.69 +15.5% | 20.8% | CHF 1,491.00 | CHF 480.11 | CHF 1,266.00 | 15 |
Feb ’24 | CHF 858.40 | CHF 1,015.69 +18.3% | 20.8% | CHF 1,491.00 | CHF 480.11 | CHF 1,172.00 | 15 |
Jan ’24 | CHF 818.80 | CHF 1,137.11 +38.9% | 21.1% | CHF 1,540.00 | CHF 480.11 | CHF 1,212.50 | 15 |
Dec ’23 | CHF 943.40 | CHF 1,153.51 +22.3% | 20.8% | CHF 1,540.00 | CHF 480.11 | CHF 1,157.00 | 14 |
Nov ’23 | CHF 897.60 | CHF 1,162.65 +29.5% | 20.6% | CHF 1,540.00 | CHF 480.11 | CHF 965.80 | 14 |
Analyst Forecast: Target price is less than 20% higher than the current share price.